4//SEC Filing
Sheehy Douglas T. 4
Accession 0000899243-20-012855
CIK 0001631650other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:23 PM ET
Size
6.2 KB
Accession
0000899243-20-012855
Insider Transaction Report
Form 4
Sheehy Douglas T.
See Remarks
Transactions
- Award
Common Stock, $0.0001 par value
2020-05-10+2,420→ 55,378 total
Footnotes (4)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest as to 100% of the underlying shares on September 11, 2020 (the "Vesting Date"), subject to the Reporting Person's continued service relationship with the Issuer on the Vesting Date.
- [F2]Includes 11,250 RSUs and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]Includes 9,375 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F4]Includes 21,492 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001488637
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 5:23 PM ET
- Size
- 6.2 KB